Robert Haigh
Fondatore presso KalVista Pharmaceuticals Ltd.
Posizioni attive di Robert Haigh
Società | Posizione | Inizio | Fine |
---|---|---|---|
KalVista Pharmaceuticals Ltd.
KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom. | Direttore operativo | 10/08/2011 | - |
Fondatore | 01/01/2011 | - | |
CHAIN Biotechnology Ltd.
CHAIN Biotechnology Ltd. BiotechnologyHealth Technology CHAIN Biotechnology Ltd. develops new clostridium-based microbial technology for high value healthcare products. It produces novel 2nd generation live bio therapeutic products (LBPs) for chronic gut-related diseases, such as Inflammatory Bowel Disease (IBD). The company was founded by Edward Green and Basil Omar in 2014 and is headquartered in Marlow, the United Kingdom. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Robert Haigh
Precedenti posizioni note di Robert Haigh
Società | Posizione | Inizio | Fine |
---|---|---|---|
Macomics Ltd.
Macomics Ltd. Miscellaneous Commercial ServicesCommercial Services Macomics Ltd. engages in research and experimental development on biotechnology. The company was founded by Jeffrey William Pollard and Luca Cassetta on November 6, 2018 and is headquartered in Edinburgh, the United Kingdom. | Amministratore Delegato | - | - |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Direttore Tecnico/Scientifico/R&S | - | - |
Ferring Research Institute, Inc.
Ferring Research Institute, Inc. Drugstore ChainsRetail Trade Ferring Research Institute, Inc. is a biopharmaceutical company, which engages in identifying, developing, and marketing of products. It focuses on the fields of endocrinology, gastroenterology, infertility, obstetrics, urology and osteoarthritis. The company is headquartered in San Diego, CA. | Direttore Tecnico/Scientifico/R&S | - | - |
Vantia Ltd.
Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Vantia Ltd. services to provide molecule agonists of vasopressin receptors. It offers healthcare improve clinical treatments through development and commercialization of innovative medicines. The company was founded by Robert Haigh and Chris Yea in 2008 and is headquartered in Southampton, the United Kingdom. | Direttore/Membro del Consiglio | 24/11/2009 | - |
Direttore Tecnico/Scientifico/R&S | 01/01/2007 | - | |
Fondatore | 24/11/2009 | - |
Formazione di Robert Haigh
The University of Manchester | Doctorate Degree |
Statistiche
Distribuzione geografica
Regno Unito | 5 |
Stati Uniti | 3 |
Israele | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 3 |
Director/Board Member | 2 |
Founder | 2 |
Settori
Health Technology | 4 |
Commercial Services | 3 |
Retail Trade | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 6 |
---|---|
Vantia Ltd.
Vantia Ltd. Miscellaneous Commercial ServicesCommercial Services Vantia Ltd. services to provide molecule agonists of vasopressin receptors. It offers healthcare improve clinical treatments through development and commercialization of innovative medicines. The company was founded by Robert Haigh and Chris Yea in 2008 and is headquartered in Southampton, the United Kingdom. | Commercial Services |
Ferring Pharmaceuticals, Inc.
Ferring Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ferring Pharmaceuticals, Inc. develops and markets fertility and endocrinology products. Its products include Bravelle, Repronex, Novarel, Acthrel and Desmopressin Acetate. The company's products are used in treatment of osteoarthritis, prostate cancer, and other infertility related diseases. Ferring Pharmaceuticals was founded in 1951 and is headquartered in Parsippany, NJ. | Health Technology |
Ferring Research Institute, Inc.
Ferring Research Institute, Inc. Drugstore ChainsRetail Trade Ferring Research Institute, Inc. is a biopharmaceutical company, which engages in identifying, developing, and marketing of products. It focuses on the fields of endocrinology, gastroenterology, infertility, obstetrics, urology and osteoarthritis. The company is headquartered in San Diego, CA. | Retail Trade |
KalVista Pharmaceuticals Ltd.
KalVista Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology KalVista Pharmaceuticals Ltd. develops novel plasma kallikrein inhibitors. It also engages in the development of serine protease inhibitors and novel plasma kallikrein inhibitors represent a, approach to the treatment of DME, a leading cause of adult visual loss, plasma kallikrein inhibitors target a distinct molecular pathway and as such have the potential to offer those patients an effective treatment option. The firm has a clinical and advanced pre-clinical product pipeline targeting both intravitreal injection and oral administration, and its plasma kallikrein inhibitors can be applied to additional indications in ophthalmology. The company was founded by Lloyd Paul Aiello, Andrew Crockett, Robert Haigh and Edward P. Feener in 2011 and is headquartered in Porton Down, the United Kingdom. | Health Technology |
Macomics Ltd.
Macomics Ltd. Miscellaneous Commercial ServicesCommercial Services Macomics Ltd. engages in research and experimental development on biotechnology. The company was founded by Jeffrey William Pollard and Luca Cassetta on November 6, 2018 and is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
CHAIN Biotechnology Ltd.
CHAIN Biotechnology Ltd. BiotechnologyHealth Technology CHAIN Biotechnology Ltd. develops new clostridium-based microbial technology for high value healthcare products. It produces novel 2nd generation live bio therapeutic products (LBPs) for chronic gut-related diseases, such as Inflammatory Bowel Disease (IBD). The company was founded by Edward Green and Basil Omar in 2014 and is headquartered in Marlow, the United Kingdom. | Health Technology |
- Borsa valori
- Insiders
- Robert Haigh
- Esperienza